What is the Twilight Litaka Pharma Ltd share price today?

The Twilight Litaka Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹4.25 today.

What is the Market Cap of Twilight Litaka Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Twilight Litaka Pharma Ltd is ₹10.53 Cr. as of 10 Dec ‘14

What is the PE and PB ratio of Twilight Litaka Pharma Ltd?

The PE and PB ratios of Twilight Litaka Pharma Ltd is 0 and -0.05 as of 10 Dec ‘14

What is the 52 Week High and Low of Twilight Litaka Pharma Ltd?

The 52-week high/low is the highest and lowest price at which a Twilight Litaka Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Twilight Litaka Pharma Ltd is ₹0 and ₹0 as of 10 Dec ‘14

What is the CAGR of Twilight Litaka Pharma Ltd?

Twilight Litaka Pharma Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at N/I%.

What is the shareholding pattern of Twilight Litaka Pharma Ltd?

The shareholding pattern of Twilight Litaka Pharma Ltd is as follows: Promoters - N/I % Institutions - N/I % Public - N/I %

Twilight Litaka Pharma Ltd Stock Price: Share Price Today

Twilight Litaka Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹4.45

Prev. Close

₹4.25

Turnover(Lac.)

₹0.37

Day's High

₹4.45

Day's Low

₹4.15

52 Week's High

₹0

52 Week's Low

₹0

Book Value

₹-59.61

Face Value

₹5

Mkt Cap (₹ Cr.)

10.53

P/E

EPS

Divi. Yield

Twilight Litaka Pharma Ltd Corporate Action

No Record Found

Twilight Litaka Pharma Ltd NEWS AND UPDATE

No Record Found

Y/e 31 Mar( In .Cr)	Jun-2014	Jun-2013	Mar-2012	Mar-2011
Equity Capital	12.39	12.39	12.39	18.17
Preference Capital	0	0	0	0
Reserves	-133.3	6.29	169.03	136.89
Net Worth	-120.91	18.68	181.42	155.06
Minority Interest

Y/e 31 Mar( In .Cr)	Jun-2014	Jun-2013	Mar-2012	Mar-2011
Revenue	31.5	337.49	730.18	657.34
yoy growth (%)	-90.66	-53.77	11.08
Raw materials	-19.89	-296.54	-561.8	-505.86
As % of sales	63.15	87.86	76.94	76.95
Employee costs	-4.81	-10.12	-19.98	-17.67

Y/e 31 Mar( In .Cr)	Jun-2014	Jun-2013	Mar-2012	Mar-2011
Profit before tax	-14.12	-48.32	19.47	63.38
Depreciation	-4.97	-6.4	-5.1	-3.64
Tax paid	0	0	-0.92	-13.93
Working capital	-120.21	-141.58	55.95
Other operating items

Y/e 31 Mar	Jun-2014	Jun-2013	Mar-2012
Growth matrix (%)
Revenue growth	-90.66	-53.77	11.08
Op profit growth	-78.72	-160	-30.14
EBIT growth	-71.02	-173.41	-33.96
Net profit growth	-13.13	-4,712.22	-92.88

Particulars (Rupees in Crores.)	Jun-2014	Mar-2012	Mar-2011
Gross Sales	31.5	732.55	670.83
Excise Duty	0	0	0
Net Sales	31.5	732.55	670.83
Other Operating Income	0	0	0
Other Income	0	1.11	3.25

Twilight Litaka Pharma Ltd Peer Comparison

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceutical Industries Ltd SUNPHARMA	1,688.35	128.62	4,05,187.69	1,181.05	0.8	5,985.33	98.33
Divis Laboratories Ltd DIVISLAB	5,387.3	69.02	1,43,074.29	594	0.56	2,297	513.62
Cipla Ltd CIPLA	1,432.55	24.87	1,15,767.88	1,438.15	0.91	4,134.87	360.73
Torrent Pharmaceuticals Ltd TORNTPHARM	3,246.6	60.19	1,09,803.69	485	0.86	2,330	222.38
Mankind Pharma Ltd MANKIND	2,347.5	50	96,689.84	416.38	0	2,396.57	334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Twilight Litaka Pharma Ltd

Management

Register Office

Registrar Office

Chairman

R C Bora

Managing Director

Gopal Ramourti

Executive Director & CFO

N R Bora

Director

A S Chandvankar

Director

M S Raghavan Ayyangar

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by Twilight Litaka Pharma Ltd

Summary

Incorporated as a private limited company in Jan.74, Li Taka Pharmaceuticals was converted into a public limited company in Dec.85. Li Taka Laboratories Pvt Ltd was amalgamated with the company in 1986.The company is engaged in the manufacture of various drugs and pharmaceuticals formulations. It also manufactures formulations on loan licence basis as well as on principal to principal basis for various multinational companies like Hindustan Ciba Geigy, Pfizer and Burroughs Wellcome. Its manufacturing facility is located at Pimpri, Pune.The company came out with a rights issue in Apr.92 to meet the long-term working capital requirements of the company and to part-finance its normal capital expenditure including modernisation.In Jun.95, Pegasus Laboratories was amalgamated with the company. The company exported goods worth Rs 1.14 cr in 1996-97.During 1997-98, the company has purchased Marketing division of Borachem Industries Ltd., With this arrangement the companys product will be represented in almost all the major parts of the country. There is a rise of 88.53% in the sales over the previous year. To give more emphasis on own operations the marketing alliance with Smithkline Beecham Pharmaceuticlas (I) Ltd. has been terminated.The company is planning to introduce new products for domestic and internation market.
Read More